OLVIG
CERE

Oliver Lagore Vanvalin Investment Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-60
Closed -$2.54K – 862
2023
Q4 		$2.54K Buy
+60
New +$2.54K ﹤0.01% 601